Page 2 - Oxford University

Kavitha to speak on Telangana govt's achievements at Oxford University

Ruling BRS MLC in Telangana K Kavitha will be delivering a keynote lecture at the Oxford University in London on October 30 on the schemes undertaken by Chief Minister K Chandrashekar Rao-led government in the state and about the progress achieved in different fields. Kavitha has been invited by Oxford University for a lecture as part of development economics, a release from Kavitha's office said here on Tuesday. "CM KCR led Telangana government's programmes have gained international recognition. Oxford University has acknowledged Telangana's rapid progress in India. This recognition comes as a result of the various initiatives undertaken by the state government," it said. In recent years, several programmes launched by the chief minister have attracted Oxford University's attention, it said. During her recent visit to London as part of the Bridge India initiative, Kavitha spoke to students from different colleges about the significant strides made by KCR in Telangana's ...

UN authorises 2nd malaria vaccine, experts say not enough to stop spread

The World Health Organization has authorised a second malaria vaccine, a decision that could offer countries a cheaper and more readily available option than the world's first shot against the parasitic disease. WHO Director-General Tedros Adhanom Ghebreyesus said the UN health agency was approving the new malaria vaccine based on the advice of two expert groups, recommending its use in children at risk of the disease. As a malaria researcher, I used to dream of the day we would have a safe and effective vaccine against malaria. Now we have two, Tedros said. Oxford University developed the new three-dose vaccine with help from the Serum Institute of India. Research suggests it is more than 75 per cent effective and that protection is maintained for at least another year with a booster. Tedros said the shot would cost about USD 2 to USD 4 and could be available in some countries next year if funders agree to buy it. Earlier this year, regulatory authorities in Ghana and Burkina Faso

Can Oxford and Cambridge save Harvard from AI's educational Armageddon

What can be done to avoid a future in which AI institutionalises cheating and robs education of any real content? This question is stirring an anxious debate in the university world

IIT Bombay top Indian educational institute, 149th globally: QS Rankings

IIT Delhi comes next with a global rank of 197, followed by IISc Bangalore at 225

China's Covid-19 cover-up had huge help from Western elites: Report

WHO, the chief global health watchdog, played the role of a megaphone for China's claims about the virus' origin too many times to count, The New York Post wrote

Ghana becomes first country to approve Oxford malaria vaccine for children

It is hoped that this crucial step will enable the vaccine to help Ghanaian and African children to effectively combat malaria, said Oxford University

Oxford University, SII tie-up delivers 'high efficacy' malaria vaccine

A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday. The R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use in children aged 5 to 36 months the age group at the highest risk of death from malaria. It marks the first regulatory clearance for the R21/Matrix-M malaria vaccine for use in any country. This marks a culmination of 30 years of malaria vaccine research at Oxford with the design and provision of a high efficacy vaccine that can be supplied at adequate scale to the countries who need it most, said Professor Adrian Hill, Chief investigator of the programme and Director of the Oxford University's Jenner Institute at the Nuffield Department of Medicine. As with the Oxford-AstraZeneca COVID-19 vaccine, our partnership with the Serum Institute of India has

Indian-origin Meghana Pandit named CEO of Oxford University Hospitals

Professor Meghana Pandit, a leading Indian-origin medic was appointed the chief executive officer (CEO) of the Oxford University Hospitals NHS Foundation Trust, one of the UK's largest teaching hospitals. Pandit becomes the trust's first female chief and she is also the first person of Indian heritage to be appointed CEO of any National Health Service (NHS) trust in the Shelford Group, which represents some of the biggest teaching hospitals in the country. Pandit, who was serving as the interim CEO at Oxford University Hospitals (OUH) since July 2022, was permanently appointed to the post following a rigorous and competitive process, which concluded after what OUH described as an extensive national and international recruitment search. It is a privilege to be asked to lead OUH on a permanent basis and I look forward to continue working with colleagues at OUH, our partners in the health and social care system in Oxfordshire and across the BOB Integrated Care System, our partner ...

Here's how Oxford zeroes in on its word of the year as people vote for 2022

As OUP leaves the word of the year to a people's vote, here's how the process works

As China intensifies Covid-19 lockdowns, India gradually opens up

Data shows that spike in one country has not coincided with a rise the other

7 Indian universities on Global Employability University Ranking, IIT-D top

Seven Indian universities featured on the list released by the Times Higher Education

Poverty in India fell by 415 million in 15 yrs; still has maximum poor: UN

Global Multidimensional Poverty Index has revealed that COVID-19 pandemic had set progress in reducing poverty back by 3-10 years

A remarkable teacher: Remembering D-School's Elizabeth Krishna

Elizabeth Krishna worked at the Delhi School of Economics for about a decade and a half from the mid-1960s to late 1970s as a tutor, or teaching assistant

Oxford University shifts focus to health threat triggering future pandemics

Oxford said the organization will seek to learn from the response to Covid and take advantage of the university's research and global partnerships

Covid-19: Experts bat for mixing vaccines in the wake of BA.2.75 variant

Senior research fellow at Oxford say BA.2.75 has several mutations in the spike protein, two of which are unique to it when compared to its parent strain BA.2

Four women who took on the Oxford establishment

The biographical material in Metaphysical Animals is evocative and sparkling

India invited to join G7 Health Ministers' Summit virtually: UK Government

India is among the guest countries invited to join virtually at the 2021 G7 Health Ministers' Meeting to be held at Oxford University on June 3 and 4

The fine art of sustainable living

This is a deeply personal memoir of a woman born in New Jersey, whose Native American Osage mother and her family introduced her to nature and spirituality early on

UK marks Oxford/AstraZeneca Covid-19 vaccine's one-year anniversary

Our fight against COVID in the UK and around the world would not have been possible without the Oxford/AstraZeneca vaccine, said PM Boris Johnson

Billionaire Poonawalla family pledges $66 mn to Oxford for research campus

The pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world's largest maker of vaccines